Objective: To describe the experience in 22 patients with penile cancer.
Methods: observational, cross-sectional study. There were included patients with complete medical records and histopathologic report of penile cancer during the period 2010-2013.
Results: The mean age was 64.95 years, evolution time to diagnosis was 25 months, 68.2 % smoked and presented HPV infection, all had phimosis, 72.7% had pain in the penis and groin, 81.8% had palpable nodules and 45.5% lesions > 3cm; 86.3% were diagnosed with clinical stage IIIA and higher, 59.1% underwent partial penectomy, 86.4% were squamous cell variety, 40.9% of the patients died at 6 months post-surgery, 66.6% of smokers presented metastasis, all those positive for HPV infection and smoking had neurovascular invasion and died; 83.3% (n=6) that underwent partial penectomy and positive lymph node dissection with metastases died. Overall survival was 40.9 % at 5 years and the average survival time was 41.8 months.
Conclusion: we conclude that penile cancer remains rare, which has a high mortality and the diagnosis is made late. Measures for the realization of a timely diagnosis are suggested this may improve the prognosis and the treatment time can be curative.
Manuscripts that are Published Ahead of Print have been peer reviewed and accepted for publication by the Editorial Board of the West Indian Medical Journal. They may appear in their original format and may not be copy edited or formatted in the style guide of this Journal. While accepted manuscripts are not yet assigned a volume, issue or page numbers, they can be cited using the DOI and date of e-publication. See our Instructions for Authors on how to properly cite manuscripts at this stage. The contents of the manuscript may change before it is published in its final form. Manuscripts in this section will be removed once they have been issued to a volume and issue, but will still retain the DOI and date of e-publication.